Automated lipid nanoparticle platform promises faster RNA therapy design
MIT chemical engineers have built an automated, self-correcting platform that rapidly produces lipid nanoparticles of precisely controlled sizes and shapes, ...
MIT chemical engineers have built an automated, self-correcting platform that rapidly produces lipid nanoparticles of precisely controlled sizes and shapes, ...
A new Science study shows that gut bacteria, particularly flagellin-producing Lachnospiraceae, and diet influence whether people develop fever after mRNA ...
New research shows that synthetic lipid nanoparticles trigger irregular calcium signals in cells partly through the pain-sensing ion channel TRPA1, ...
The AACR Cancer Progress Report 2026 documents 11 new FDA drug approvals, a 35 percent decline in cancer deaths since ...
A BMJ investigation reveals that US health officials relied on a flawed vaccine safety algorithm, suppressed internal warnings, and delayed ...
A new review in Materials Today Bio proposes a bottleneck-first framework for evaluating antigen delivery platforms in therapeutic cancer vaccines, ...
A new review details how nanoparticles disguised with red blood cell membranes, exosomes, and synthetic coatings, loaded with personalized neoantigens, ...
A new review charts how mRNA, peptide, cell, and virus-based therapeutic vaccines, supercharged by AI-driven neoantigen prediction and combination immunotherapy, ...
A German study of 114 allogeneic stem cell transplant recipients shows that mRNA vaccination against SARS-CoV-2 is safe and largely ...
An AI framework called AGENT has engineered solid-state mRNA vaccines that retain full bioactivity after two months at 37 degrees ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine